29
Views
12
CrossRef citations to date
0
Altmetric
Technical Paper

Rotation of a Neutral Beamline to Obtain Counter-Injection on the DIII-D Tokamak

Pages 398-403 | Published online: 07 Apr 2017
 

Abstract

Until the recent experimental campaign in 2006, all the neutral beam systems on the DIII-D tokamak injected power with the momentum in the same direction as the usual plasma current (“co-injection”). A major modification made during the April 2005-March 2006 shutdown period rotated one of the two-source beamlines to allow injecting power with the momentum opposite that of the plasma current (“counter-injection”). This modification provides the capability of injecting up to 10 MW of neutral beam power with zero net momentum input to the plasma. Decoupling the injected momentum and power opens a previously inaccessible parameter space for experiments that study the effect of rotation on various plasma instabilities, transport, and operational scenarios.

Rotating the 5 MW neutral beamline presented significant technical challenges. The beamline and several major subsystems required extensive dismantling and rebuilding, and a careful alignment of the ion sources was required to document the new injection paths. We present a summary of the tasks required for the beamline rotation, describe major technical issues addressed, and discuss the advantages of the new configuration.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.